by Danny Sullivan – Longevity Technology
Best-selling author says that more investment into more hallmarks of aging is needed to drive the longevity field forward.
“There are lots of other hallmarks of aging – at least eight to ten – that aren’t receiving the same level of investor attention. I think there are probably some great opportunities out there for investors who are willing to comb through some of the less flashy stuff that gets less press than other areas.”
Steele’s hope is that investment will also extend into the basic science needed to advance some of these areas to the point where potential treatments are ready to turn into biotech or pharma endeavors.
